Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thyroid hormone receptor beta is a nuclear hormone receptor encoded by the THRB gene located on chromosome 3. It functions primarily as a ligand-dependent transcription factor that mediates cellular responses to triiodothyronine (T3) and thyroxine (T4), regulating genes involved in development, differentiation, metabolism—especially hepatic lipid and carbohydrate pathways—and feedback control of TSH secretion from the pituitary gland. The predominant isoforms are expressed mainly in liver, kidney, pituitary gland, and brain. Mutations can cause resistance to thyroid hormones with clinical manifestations ranging from goiter without typical hyperthyroidism symptoms to metabolic disturbances. Loss or downregulation has been implicated in certain cancers where it may function as a tumor suppressor gene[1][2][6][8].
Drugs targeting this molecule typically act as agonists that selectively bind to and activate the beta isoform of the thyroid hormone receptor. This leads to modulation of gene expression involved in cholesterol and triglyceride metabolism with reduced cardiac side effects compared to non-selective agonists[3][7].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thyroid hormone receptor beta (THRB).